Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of Zilretta (FX006) in
bursal injections and to assess the patient's impression to change in treatments, to their
chronic pain.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston